Document is current
Any future updates will be listed below
-
Authors
Sun, Qianqian
Shi, Yixing
Wang, Leiming
Bai, Lin
Hu, Wanming
Xu, Yuqiao
Piao, Yueshan
Qi, Xueling
Liu, Jiang
Guan, Hongzhi
Shi, Wei
Yu, Yang
-
Funding
Funding for this research was provided by:
Beijing Natural Science Foundation (7264305)
Beijing Nova Program (Z20110000682014)
Beijing Nova Program (Z211100002121041, 20230484485)
National Natural Science Foundation of China (32471041)
National Natural Science Foundation of China (32170550)
- License Information
-
More Information
Article History
Received: 6 January 2026
Revised: 18 April 2026
Accepted: 18 April 2026
First Online: 27 April 2026
Declarations
:
: Y.Y., W. S, Y.S., Q.S., LM.W. have a pending patent application encompassing methodologies for developing the monoclonal anti-BEND2 antibody in this paper, as well as the use of this antibody for diagnosing BEND2-fusion tumors. The authors declare no other competing interests.
